Why PHARMAC should fund SMA drug

New Zealand Herald

14 April 2019 - How must it feel to make decisions upon which lives depend?

That is often the role in which PHARMAC finds itself — the Government agency that decides which drugs should be publicly funded. It is a job few of us would envy.

PHARMAC balances a series of factors to make its decisions — but in essence it must weigh up a limited budget against which pharmaceuticals have the best chance of success.

Read New Zealand Herald editorial

Michael Wonder

Posted by:

Michael Wonder